Addus HomeCare (NASDAQ:ADUS) Now Covered by KeyCorp

KeyCorp began coverage on shares of Addus HomeCare (NASDAQ:ADUS) in a research note released on Friday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $150.00 price target on the stock.

Several other research firms have also recently issued reports on ADUS. StockNews.com cut Addus HomeCare from a strong-buy rating to a buy rating in a research report on Sunday, July 7th. Royal Bank of Canada reissued an outperform rating and set a $141.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They set an outperform rating and a $136.00 price target on the stock. Stephens reaffirmed an overweight rating and issued a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. Finally, TD Cowen increased their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a buy rating in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of Moderate Buy and a consensus price target of $131.38.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $130.63 on Friday. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $136.12. The company has a market capitalization of $2.36 billion, a P/E ratio of 32.41, a PEG ratio of 2.33 and a beta of 1.04. The stock has a 50-day simple moving average of $129.54 and a 200-day simple moving average of $117.34.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.94 EPS. As a group, analysts forecast that Addus HomeCare will post 4.58 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock valued at $3,050,082 over the last quarter. Insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Creative Planning grew its position in Addus HomeCare by 5.8% during the 3rd quarter. Creative Planning now owns 4,910 shares of the company’s stock worth $653,000 after purchasing an additional 267 shares in the last quarter. Oliver Luxxe Assets LLC lifted its stake in shares of Addus HomeCare by 244.8% in the 3rd quarter. Oliver Luxxe Assets LLC now owns 16,512 shares of the company’s stock valued at $2,197,000 after purchasing an additional 11,723 shares during the last quarter. Redhawk Wealth Advisors Inc. acquired a new stake in shares of Addus HomeCare in the 3rd quarter valued at $922,000. Inspire Investing LLC lifted its stake in shares of Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after purchasing an additional 100 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after purchasing an additional 191 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.